Specialized platform models supersede universal mRNA applications
Biotech platforms built on targeted delivery mechanisms for specific cell types or tissues offer a scientifically defensible model compared to broad, universal-platform assumptions.
Sign in to read the full idea
The argument, what validates it, the risks discussed and hearing it from the source are for signed-in members. Free accounts read 3 ideas in full a day — no card required.